Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Lohri

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Leukemia & Lymphoma|April 15, 2003
HIV-testing and newly-diagnosed malignant lymphomas. The SAKK 96/90 registration studyGiannicola D'Addario, Alexander Dieterle, Joachim Torhorst, et al.
Swiss Medical Weekly|August 5, 2011
Diagnosis and treatment of follicular lymphomaFelicitas Hitz, Nicolas Ketterer, Andreas Lohri, et al.
Journal of Clinical Lipidology|January 10, 2018
Dyslipidemia and lipid-lowering treatment in a hematopoietic stem cell transplant cohort: 25 years of follow-up dataMelanie Premstaller, Melanie Perren, Kuebra Koçack, et al.
Leukemia & Lymphoma|February 14, 2013
Brentuximab vedotin (SGN-35) in patients with transplant-naive relapsed/refractory Hodgkin lymphomaStephanie Sasse, Achim Rothe, Helen Goergen, et al.
Blood|July 13, 2012
Brentuximab vedotin for relapsed or refractory CD30+ hematologic malignancies: the German Hodgkin Study Group experienceAchim Rothe, Stephanie Sasse, Helen Goergen, et al.
Onkologie|May 27, 2010
Intense therapy in patients with locally advanced esophageal cancer beyond hope for surgical cure: a prospective, multicenter phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 76/02)Thomas Ruhstaller, Arnoud Templeton, Karin Ribi, et al.
Swiss Medical Weekly|July 26, 2018
Diagnosis and treatment of follicular lymphoma: an updateMario Bargetzi, Reto Baumann, Sergio Cogliatti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
Long-term follow-up of patients with follicular lymphoma receiving single-agent rituximab at two different schedules in trial SAKK 35/98Giovanni Martinelli, Shu-Fang Hsu Schmitz, Urs Utiger, et al.
Lancet (London, England)|June 28, 2002
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trialNorbert Schmitz, Beate Pfistner, Michael Sextro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trialAndreas Engert, Andreas Josting, Heinz Haverkamp, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Leukemia & Lymphoma|April 15, 2003
HIV-testing and newly-diagnosed malignant lymphomas. The SAKK 96/90 registration studyGiannicola D'Addario, Alexander Dieterle, Joachim Torhorst, et al.
Swiss Medical Weekly|August 5, 2011
Diagnosis and treatment of follicular lymphomaFelicitas Hitz, Nicolas Ketterer, Andreas Lohri, et al.
Journal of Clinical Lipidology|January 10, 2018
Dyslipidemia and lipid-lowering treatment in a hematopoietic stem cell transplant cohort: 25 years of follow-up dataMelanie Premstaller, Melanie Perren, Kuebra Koçack, et al.
Leukemia & Lymphoma|February 14, 2013
Brentuximab vedotin (SGN-35) in patients with transplant-naive relapsed/refractory Hodgkin lymphomaStephanie Sasse, Achim Rothe, Helen Goergen, et al.
Blood|July 13, 2012
Brentuximab vedotin for relapsed or refractory CD30+ hematologic malignancies: the German Hodgkin Study Group experienceAchim Rothe, Stephanie Sasse, Helen Goergen, et al.
Onkologie|May 27, 2010
Intense therapy in patients with locally advanced esophageal cancer beyond hope for surgical cure: a prospective, multicenter phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 76/02)Thomas Ruhstaller, Arnoud Templeton, Karin Ribi, et al.
Swiss Medical Weekly|July 26, 2018
Diagnosis and treatment of follicular lymphoma: an updateMario Bargetzi, Reto Baumann, Sergio Cogliatti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
Long-term follow-up of patients with follicular lymphoma receiving single-agent rituximab at two different schedules in trial SAKK 35/98Giovanni Martinelli, Shu-Fang Hsu Schmitz, Urs Utiger, et al.
Lancet (London, England)|June 28, 2002
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trialNorbert Schmitz, Beate Pfistner, Michael Sextro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trialAndreas Engert, Andreas Josting, Heinz Haverkamp, et al.
Pageof 4